Pleiotropic actions of peroxisome proliferator–activated receptors in lipid metabolism and atherosclerosis

O Barbier, IP Torra, Y Duguay, C Blanquart… - … , and vascular biology, 2002 - Am Heart Assoc
Peroxisome proliferator–activated receptors (PPARs) are nuclear receptors activated by fatty
acids and derivatives. Although PPARα mediates the hypolipidemic action of fibrates …

Rosiglitazone: a review of its use in the management of type 2 diabetes mellitus

AJ Wagstaff, KL Goa - Drugs, 2002 - Springer
Rosiglitazone, a thiazolidinedione with a different side chain from those of troglitazone and
pioglitazone, reduces plasma glucose levels and glucose production and increases glucose …

Unique ability of troglitazone to up-regulate peroxisome proliferator-activated receptor-γ expression in hepatocytes

GF Davies, PJ McFie, RL Khandelwal… - Journal of Pharmacology …, 2002 - ASPET
Peroxisome proliferator-activated receptor-γ (PPAR-γ) is a nuclear receptor that is activated
by the binding of an appropriate ligand. Several studies have demonstrated that certain …

Leptin in anorexia nervosa and bulimia nervosa: importance of assay technique and method of interpretation

R Frederich, S Hu, N Raymond, C Pomeroy - Journal of Laboratory and …, 2002 - Elsevier
Studies of the role of leptin in patients with anorexia nervosa and bulimia nervosa have
conflicted in their data and interpretation. Such differences may be a result of the assay …